| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3120ae9cab5bb4831f0cc16288966367
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_77318fdb22b7d91f9f89dfc2627cb2c5 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-755
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-755 |
| filingDate |
2018-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2021-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8dd716fa68199304220df97c7449cb6a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8c586513bf31c266f21c00f41a83ae81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d54fb9933861b791c7eeb68c1af0af0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8b49c481cf1a2dcc799641a3e788c4db
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_44b2ab5596b5f06aed1f6600de02334f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e24b1b3f3f14533c7b37655a0f51da8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3a8fc0cedc8b62bd0afadcc5ae532a65
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a6f253eb33c1116e0f0baafad5706e81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06785bb6652966d59be6208ee7161d22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_def7335311f7813b9272c6b7089c6f22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9af120f73345c81bbcdb72039a945141 |
| publicationDate |
2021-02-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-10906960-B2 |
| titleOfInvention |
Factor VIII variants having a decreased cellular uptake |
| abstract |
The present invention relates to modified coagulation factors. In particular, the present invention relates to modied Factor VIII molecules having decreased cellular uptake. |
| priorityDate |
2010-09-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |